Thymosin ?1 is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene.
It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Unlike ? thymosins, to which it is genetically and chemically unrelated, thymosin ?1 is produced as a 28-amino acid fragment, from a longer, 113-amino acid precursor, prothymosin ?.
This report elaborates the market size, market characteristics, and market growth of the Thymosin Alpha-1 industry, and breaks down according to the type, application, and consumption area of Thymosin Alpha-1. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Thymosin Alpha-1 in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Thymosin Alpha-1 market covered in Chapter 13:
Hainan Zhonghe Pharmaceutical Co., Ltd.
Chengdu Shengnuo Biopharm Co., Ltd.
Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical Co., Ltd.
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Manus Aktteva Biopharma LLP
Harbin Pharmaceutical Group Bio-Engineering Co., Ltd.
Zadzxin
SPH No. 1 Biochemical & Pharmaceutical Co., Ltd.

In Chapter 6, on the basis of types, the Thymosin Alpha-1 market from 2015 to 2025 is primarily split into:
1g
5g
10g
50g
Others

In Chapter 7, on the basis of applications, the Thymosin Alpha-1 market from 2015 to 2025 covers:
Chronic Hepatitis B
Acute Severe Hepatitis
Adjuvant Therapy for Tumor
Immuno Compromised Diseases
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025